KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other Working Capital Changes (2018 - 2025)

ClearPoint Neuro's Other Working Capital Changes history spans 13 years, with the latest figure at $402000.0 for Q3 2025.

  • For Q3 2025, Other Working Capital Changes fell 75.91% year-over-year to $402000.0; the TTM value through Sep 2025 reached -$706000.0, down 372.59%, while the annual FY2024 figure was -$597000.0, 2613.64% down from the prior year.
  • Other Working Capital Changes for Q3 2025 was $402000.0 at ClearPoint Neuro, up from -$303000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $1.7 million in Q3 2024 and bottomed at -$1.7 million in Q2 2024.
  • The 5-year median for Other Working Capital Changes is $39000.0 (2024), against an average of -$22000.0.
  • The largest annual shift saw Other Working Capital Changes plummeted 900.0% in 2022 before it soared 598.33% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $291000.0 in 2021, then soared by 39.52% to $406000.0 in 2022, then crashed by 46.06% to $219000.0 in 2023, then tumbled by 390.87% to -$637000.0 in 2024, then soared by 163.11% to $402000.0 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Other Working Capital Changes are $402000.0 (Q3 2025), -$303000.0 (Q2 2025), and -$168000.0 (Q1 2025).